Development of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ): A New Patient-Reported Outcome (PRO) Instrument.

Matthew ReaneyVeleka AllenAmy J SehnertLiang FangAlbert A HagègeSrihari S NaiduIacopo Olivotto

Published in: PharmacoEconomics - open (2022)

Our findings support the HCMSQv1.0 as a fit-for-purpose PRO instrument for assessing treatment benefit in patients with HCM. Studies in larger patient populations are ongoing to confirm responder definition and scoring approaches encompassing key HCM symptoms.

Keyphrases

hypertrophic cardiomyopathy
patient reported outcomes
left ventricular
anti inflammatory
case report
cross sectional
combination therapy
psychometric properties
physical activity